An electric bicycle is a bicycle equipped with an electric motor that may be activated to assist with or replace pedalling. The earlier image of these cycles was it being a vehicle for the lazy peddlers or the elder age group people. These bikes/ bicycles allow making pedalling easier by drawing power from the attached battery. The tiring exercise can be made into a fun ride with just acceleration by the press of a button. The report titled 'Global E-Bikes Market Outlook, 2026' published by Bonafide Research identifies and discusses recent developments in electric mobility across the globe. This report not only serves with the facts, figures, and forecasts but also has a detailed study about the Covid effect on the electric bicycle industry.
Electric Bicycles are now considered an alternative eco-friendly & trendy option for public transport, fuel-run vehicles, and smart cars. This is mainly as they are cheaper in comparison to the other alternatives and are also easy to charge. This is to boost the sales of e-bikes in the coming period which is to be reflected as a market value of USD 53 Billion and an anticipated volume CAGR 8.85%. Many governments across the world are taking initiatives towards the reduction of carbon footprints and encouraging electric bicycles to use is one of the most prominent steps. This is expected to be the major market driver in the coming years. By type of propulsion, the e-bike market is classified majorly into two segments- Pedal Assisted & Throttle Mode. The main difference between the two is that in pedal-assist the rider is expected to pedal alongside the power received from the motor, whereas in the throttle mode, no pedalling is required and the bike moves solely on the power received from the motor. The market is led by the pedal-assisted, considering its advantage of allowing the rider to ride farther & faster and conquers tougher terrains. On the other hand, the throttle e-bikes allow the rider to make the motor push the bike forward at the ease of a button or a twist, and pedalling is optional. With such advantages, this segment is to have an anticipated CAGR of 9.88% in terms of volume through the forecasted period.
Based on class type, the e-bikes can be categorized as Class 1: Pedal Assist, Class 2: Throttle On Demand, & Class 3: Speed Pedelec. Of this, the market is led by the class 1 electric bicycle which is pedal-assisted, holding approximately 70% of the market share. In the majority of the states, class 1 electric bicycles are treated like mountain/ pavement bicycles which are legally allowed to be driven in the regular bicycle lanes. E-bikes that are pedal-assist only, with no throttle, and a maximum assisted speed of 28 mph, are included in the speed pedelec segment, which is expected to be growing with the highest an anticipated volume CAGR 13.41%, through the period of 2021-2026. The overall market of electric bikes can be divided into three segments based on the battery used- Lithium-Ion, Lead Acid & others. The lithium-ion battery segment is to lead the market by the end of 2026, with not much share difference from the following lead-acid segment. However, in 2015 the lead acid battery segment led the market. By the end of the forecasted year, the market lithium-ion battery-aided e-bikes segment is expected to reach 34 Million Units, while the lead-acid segment is to have a decline in the market share. The growth of the lithium-ion batteries can be sited to these being eco-friendly and life cycle & weight ratio in comparison to other batteries. The decline in the price of this battery is also one of the major reasons for its high preference in the coming years.
The major application of the e-bikes is seen in city & urban travel, as with the increasingly busy lives there has a hike in the need of daily commute. The decreasing reliability & the need to maintain the social distance is hampering the like of public transportation. On the other hand, there has been an increasing awareness about the need for sustainable environmental concerns. In order to give a solution to such challenges, e-bikes are an ideal solution for urban mobility. The use of e-bikes in urban dwellings accounted for more than 50% of the market share. One of the major application trends in the developed regions is the use of electric bikes by e-commerce and food delivery service providers. This is to give a huge boost in the market. Among the major application segments, the cargo segment is expected to be growing as the fastest segment, with a CAGR of 9.77%.
Globally, the Asia Pacific is the leading region with more than 60% of the market share in terms of both- value & volume. In China, there are more electric bikes than cars on the road. China held to nearly 75% of the e-bikes in the world as of the year 2020. Given such a huge number in China, it is not unexpected to see slower growth of e-bike production going forward as the market may be becoming saturated. The sales of electric bicycles have grown rapidly in Europe in recent years, following Asia. The market is extremely fragmented, with the major players holding a considerable share of the total market share. The majority of these companies' presence is concentrated in Asia, with Europe and North America being the other important markets.
Key Players: Yadea Group Holdings Ltd., Accell Group, Giant Manufacturing Co., Ltd., Merida Industry Co. Ltd, Pon Bikes, Rad Power Bikes Llc, Riese & Müller Gmbh, Trek Bicycle, Brompton Bicycle Limited, Specialized Bicycle Components, Inc., The Electric Bike Company, Pedego Electric Bikes
Table of Contents
1. Executive Summary
2. Report Methodology
3. Market Structure
3.1. Market Considerate
3.2. Market Definitions
4. Global Electric Bicycle (E-Bikes) Market Outlook
4.1. Market Size by Value
4.2. Market Size by Volume
4.3. Market Share
4.3.1. By Propulsion Type
4.3.2. By Class
4.3.3. By Battery Type
4.3.4. By Application
4.3.5. By Region
4.3.6. By Country
4.3.7. By Company
…continue
To access complete report visit here: https://www.bonafideresearch.com/product/211059971/global-e-bike-market
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
“Global Adaptive Cruise Control (ACC) Systems Market 2025” Report Provides Porters Five Forces Analysis Illustrates the Potency of Buyers & Suppliers Operating in the Industry & the Quantitative Analysis of The Global Market from 2019 to 2025 is Provided to Determine the Market Potential.
Quantitative analysis of the industry from 2014 to 2025 by Region, Type, Application.
Industrial chain,upstream and downstream situation involved in this market.
Request a sample of Adaptive Cruise Control (ACC) Systems Market report @ http://www.arcognizance.com/enquiry-sample/556644
Geographically, global Adaptive Cruise Control (ACC) Systems market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Access this report Adaptive Cruise Control (ACC) Systems Market @ http://arcognizance.com/report/global-adaptive-cruise-control-acc-systems-market-research-report-2019-by-manufacturers-regions-types-and-applications
